Both projects — CCHFVaccine and One Health EJP — rely on NCIPD's capacity to monitor and report on zoonotic pathogens circulating at the human-animal interface in Bulgaria and the Balkans.
NATIONAL CENTER OF INFECTIOUS AND PARASITIC DISEASES
Bulgaria's national reference center for infectious and parasitic diseases, with unique expertise in CCHF and Balkan zoonotic surveillance.
Their core work
NCIPD is Bulgaria's national reference laboratory and research center for infectious and parasitic diseases, conducting surveillance, diagnostics, and applied research on pathogens that cross the human-animal-environment interface. They hold unique institutional expertise in diseases endemic to the Balkans, most notably Crimean-Congo Haemorrhagic Fever (CCHF), a tick-borne virus for which Bulgaria is one of the highest-burden countries in Europe. In H2020 projects, they contribute national-level epidemiological data, clinical isolates, and laboratory capacity to pan-European research consortia studying zoonotic threats and foodborne pathogens. Their work sits at the intersection of public health surveillance and translational infectious disease research, making them a critical national node in European disease monitoring networks.
What they specialise in
NCIPD participated in the dedicated CCHFVaccine RIA project (2017–2025), contributing expertise in this tick-borne viral hemorrhagic fever for which the Balkans represent a major European endemic zone.
One Health EJP explicitly lists parasitology and microbiology among NCIPD's contributions to the joint programme on foodborne zoonoses and antimicrobial resistance.
Through One Health EJP, NCIPD contributes to European surveillance of foodborne zoonoses, prevention programmes, and health policy development across the food-human disease pathway.
One Health EJP's scope includes AMR as a cross-cutting emerging threat, indicating NCIPD's expanding capacity in this policy-priority area, though evidence is limited to a single project.
How they've shifted over time
In their first H2020 engagement (2017), NCIPD worked on highly specific, pathogen-focused research — CCHF vaccine development using animal models, reflecting deep laboratory expertise in a single dangerous virus. By 2018, their focus broadened dramatically: the One Health EJP brought them into a framework that spans foodborne zoonoses, surveillance systems, epidemiology, parasitology, and health policy simultaneously. This shift from narrow viral pathogen R&D toward integrated, multi-hazard surveillance and policy-relevant epidemiology reflects either a deliberate institutional strategy or the gravitational pull of large joint programme funding — both of which are increasingly common for national reference laboratories in southeastern Europe.
NCIPD appears to be evolving from a pathogen-specialist laboratory into a broader national surveillance and One Health node — a trajectory that makes them increasingly relevant for consortia building European disease monitoring infrastructure rather than purely bench-science vaccine projects.
How they like to work
NCIPD has participated exclusively as a non-coordinating partner across both H2020 projects, suggesting they function as a specialist contributor that brings national-level disease data and laboratory capacity rather than project management leadership. Despite only two projects, they are connected to 56 unique partners across 25 countries — a number consistent with participation in large joint programmes like One Health EJP, which by design aggregates dozens of national institutes across Europe. Working with them likely means plugging into their national surveillance data and Balkan-region field expertise, not expecting them to drive the research agenda.
With 56 unique consortium partners across 25 countries from just two projects, NCIPD operates within large, multi-national European research networks — particularly the One Health EJP joint programme, which by design connects national public health institutes from across the EU and associated countries. Their geographic footprint spans well beyond southeastern Europe, though their most distinctive value likely remains their Balkan-region disease data.
What sets them apart
Bulgaria and the broader Balkans are one of the few regions in Europe where Crimean-Congo Haemorrhagic Fever is genuinely endemic, making NCIPD an irreplaceable source of field isolates, clinical data, and epidemiological records for any European consortium studying tick-borne hemorrhagic fevers. As the national reference center, they also hold mandatory surveillance data on notifiable infectious and parasitic diseases in Bulgaria — data that is difficult to obtain through any other channel. For consortia needing credible southeastern European representation in health or One Health projects, NCIPD fills a geographic and institutional gap that few Bulgarian organizations can.
Highlights from their portfolio
- CCHFVaccineA long-horizon RIA project (2017–2025) developing a vaccine against one of Europe's most dangerous tick-borne hemorrhagic fevers, in which NCIPD's Balkan location and access to CCHF clinical material gives them rare scientific relevance not easily replicated by western European partners.
- One Health EJPA flagship European Joint Programme (COFUND-EJP) connecting national public health and food safety institutes across 40+ partners, positioning NCIPD within the core infrastructure of European zoonosis and AMR surveillance.